Literature DB >> 21455558

Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5.

Eun-Jung Song1, Min-Jung Kang, Yong-Seok Kim, Sun-Moon Kim, Sang-Eok Lee, Chang-Hwan Kim, Dong-Jae Kim, Jong-Hwan Park.   

Abstract

Signaling of the Toll-like receptor (TLR) is closely associated with tumor development and progression processes including cell proliferation, angiogenesis, metastasis, and immunosuppression. In this study, we examined the expression of TLR5 in gastric cancer cells and its function in cell proliferation. RT-PCR revealed that the TLR5 gene was expressed in all gastric cancer cell lines examined, SNU638, SNU601, SNU216, and AGS. The TLR5 agonist, flagellin, induced IL-8 production and NF-κB activation in the gastric cancer cell lines. In addition, flagellin enhanced the proliferation of all gastric cancer cells examined, whereas LPS did not affect that of SNU638 cells. Blockade of TLR5 using an antibody, restored the proliferation of SNU638 cells enhanced by flagellin, indicating that TLR5 is essential for cell proliferation by flagellin. Flagellin also led to phosphorylation of ERK in SNU638 cells. The ERK inhibitor, PD98059, restored the proliferation ability of SNU638 cells enhanced by flagellin, suggesting that ERK may play an important role in the proliferation of gastric cancer cells. These findings suggest that TLR5 may play an important role in tumor progression of gastric cancer via the regulation of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21455558     DOI: 10.3892/ijmm.2011.656

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  31 in total

Review 1.  Reevaluating the hype: four bacterial metabolites under scrutiny.

Authors:  E E Fröhlich; R Mayerhofer; P Holzer
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

Review 2.  Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?

Authors:  Li Yu; Liantang Wang; Shangwu Chen
Journal:  Cell Mol Life Sci       Date:  2011-11-03       Impact factor: 9.261

Review 3.  The influence of the commensal microbiota on distal tumor-promoting inflammation.

Authors:  Claire M Buchta Rosean; Melanie R Rutkowski
Journal:  Semin Immunol       Date:  2017-07-04       Impact factor: 11.130

Review 4.  TLR agonists: our best frenemy in cancer immunotherapy.

Authors:  Sabina Kaczanowska; Ann Mary Joseph; Eduardo Davila
Journal:  J Leukoc Biol       Date:  2013-03-08       Impact factor: 4.962

5.  Toll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion.

Authors:  Lijuan Wang; Yi Zhao; Jianfei Qian; Luhong Sun; Yong Lu; Haiyan Li; Yi Li; Jing Yang; Zhen Cai; Qing Yi
Journal:  Cancer       Date:  2012-08-22       Impact factor: 6.860

Review 6.  Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence.

Authors:  S D Gowing; J J Cool-Lartigue; J D Spicer; A J E Seely; L E Ferri
Journal:  Clin Exp Metastasis       Date:  2020-01-23       Impact factor: 5.150

7.  Increased Toll-like receptor 5 expression indicates esophageal columnar dysplasia.

Authors:  Olli Helminen; Heikki Huhta; Heikki Takala; Petri P Lehenkari; Juha Saarnio; Joonas H Kauppila; Tuomo J Karttunen
Journal:  Virchows Arch       Date:  2013-11-13       Impact factor: 4.064

8.  Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell carcinoma of the tongue.

Authors:  J H Kauppila; A E Mattila; T J Karttunen; T Salo
Journal:  Br J Cancer       Date:  2013-01-03       Impact factor: 7.640

9.  A synergistic interaction between transcription factors nuclear factor-κB and signal transducers and activators of transcription 3 promotes gastric cancer cell migration and invasion.

Authors:  Jiyeon Yoon; Sung Jin Cho; Young San Ko; Jinju Park; Dong Hoon Shin; In Chan Hwang; Sang Yeun Han; Seon Young Nam; Min A Kim; Mee Soo Chang; Hye Seung Lee; Woo Ho Kim; Byung Lan Lee
Journal:  BMC Gastroenterol       Date:  2013-02-12       Impact factor: 3.067

10.  Antibodies against Marinobacter algicola and Salmonella typhimurium flagellins do not cross-neutralize TLR5 activation.

Authors:  Raul Terron-Exposito; Benoit Dudognon; Inmaculada Galindo; Jose I Quetglas; Julio M Coll; Jose M Escribano; Eduardo Gomez-Casado
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.